Atlas Trials

Secukinumab in Active Non-segmental Vitiligo

Clinical trial NCT05676333 · COMPLETED

Trial details

NCT number
NCT05676333
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
VitiligoSecukinumab
Start date
2016-10-12
Primary completion
2017-12-16
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.